{"id":"W4312139226","doi":"10.1136/ijgc-2022-igcs.530","title":"TP021/#1521 FLORA-5/GOG3035: chemo-immunotherapy (paclitaxel and carboplatin ± oregovomab) as front-line treatment for patients with ovarian cancer. A phase III double blind placebo controlled, global multicenter study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Carboplatin; Medicine; Internal medicine; Cohort; Chemotherapy; Oncology; Ovarian cancer; Paclitaxel; Gastroenterology; Cancer; Surgery; Urology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001222083,0.001254789,0.001589004,0.0006178793,0.0003096298,0.0006969264,0.0009417762,0.001421042,0.00459886],"category_scores_gemma":[0.0003551221,0.0004845259,0.001011172,0.0004987115,0.0009144564,0.0005889895,0.0003222503,0.002555598,0.001022688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005881489,"about_ca_system_score_gemma":0.001317384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001385974,"about_ca_topic_score_gemma":0.003135232,"domain_scores_codex":[0.9997541,0.0001072054,0.00001243742,0.0000371749,0.00002899052,0.00006013981],"domain_scores_gemma":[0.9997222,0.00003714947,0.00004712716,0.00001939137,0.0000205816,0.000153577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7619178,0.07720417,0.003070022,0.001127062,0.001621474,0.0001633318,0.0001099721,0.000901695,0.05948963,0.0003108862,0.006602056,0.08748195],"study_design_scores_gemma":[0.6653472,0.3192985,0.007480762,0.00004376146,0.0007130147,0.0001231691,0.00004179337,0.0005388959,0.0039401,0.0001052414,0.002348832,0.00001871238],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902534,0.003210387,0.0003100776,0.0005746643,0.000229472,0.001890918,0.001166741,0.0001787668,0.002185623],"genre_scores_gemma":[0.9823883,0.003213626,0.001197107,0.001540291,0.0003317682,0.002481071,0.003292205,0.00005079938,0.005504847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00459886,"threshold_uncertainty_score":0.01538473,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04628207875614469,"score_gpt":0.4044008448915801,"score_spread":0.3581187661354354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}